Cardiovascular Systems, Inc.
CSII
Price:
$20
Market Cap:
$843.96M
Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including calcified plaque, as well as address various limitations related with surgical, catheter, and pharmacological treatment alternatives; and peripheral support products. It also provides Diamondback 360 Coronary orbital atherectomy systems (OAS), a coronary artery disease (CAD) product designed to facilitate stent delivery in patients with CAD who are a...[Read more]
Industry
Medical - Devices
IPO Date
2006-06-28
Stock Exchange
NASDAQ
Ticker
CSII
PE Ratio
[-20.83]
ROE
[-14.19%]
Current Ratio
[6.05]
Dividend Yield
[0%]
Enterprise Value
[797.83M]
Dividend History
The ROE as of November 2025 (TTM) for Cardiovascular Systems, Inc. (CSII) is -14.19%
According to Cardiovascular Systems, Inc.’s latest financial reports and current stock price. The company's current ROE is -14.19%. This represents a change of 269.15% compared to the average of -3.84% of the last 4 quarters.
Cardiovascular Systems, Inc. (CSII) Historical ROE (quarterly & annually)
How has CSII ROE performed in the past?
The mean historical ROE of Cardiovascular Systems, Inc. over the last ten years is -16.85%. The current -14.19% ROE has changed -15.79% with respect to the historical average. Over the past ten years (40 quarters), CSII's ROE was at its highest in in the June 2018 quarter at 2.78%. The ROE was at its lowest in in the March 2016 quarter at -22.32%.
Average
-16.85%
Median
-12.47%
Minimum
-55.53%
Maximum
1.27%
Cardiovascular Systems, Inc. (CSII) ROE by Quarter and Year
Discovering the peaks and valleys of Cardiovascular Systems, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 5.78%
Maximum Annual ROE = 1.27%
Minimum Annual Increase = -184.11%
Minimum Annual ROE = -55.53%
| Year | ROE | Change |
|---|---|---|
| 2022 | -14.80% | 198.88% |
| 2021 | -4.95% | -51.12% |
| 2020 | -10.13% | 5.78% |
| 2019 | -0.17% | -113.54% |
| 2018 | 1.27% | -184.11% |
| 2017 | -1.51% | -97.27% |
| 2016 | -55.53% | 135.89% |
| 2015 | -23.54% | 1.42% |
| 2014 | -23.21% | -35.47% |
| 2013 | -35.97% | -31.05% |
Cardiovascular Systems, Inc. (CSII) Average ROE
How has CSII ROE performed in the past?
The current ROE of Cardiovascular Systems, Inc. (CSII) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-9.96%
5-year avg
-5.76%
10-year avg
-16.85%
Cardiovascular Systems, Inc. (CSII) ROE vs. Peers
How is CSII’s ROE compared to its peers?
Cardiovascular Systems, Inc.’s ROE is greater than Paragon 28, Inc. (-26.80%), greater than Silk Road Medical, Inc (-35.39%), greater than Harpoon Therapeutics, Inc. (-211.56%), greater than Intercept Pharmaceuticals, Inc. (-253.45%), greater than Artivion, Inc. (-2.56%), greater than Chimerix, Inc. (-48.31%), less than Atrion Corporation (8.05%), greater than Avid Bioservices, Inc. (-44.35%), greater than Poseida Therapeutics, Inc. (-15.05%), greater than Apollo Endosurgery, Inc. (-84.92%),
| Company | ROE | Market cap |
|---|---|---|
| -26.80% | $1.10B | |
| -35.39% | $1.12B | |
| -211.56% | $865.08M | |
| -253.45% | $794.69M | |
| -2.56% | $2.15B | |
| -48.31% | $801.08M | |
| 8.05% | $809.44M | |
| -44.35% | $798.90M | |
| -15.05% | $925.93M | |
| -84.92% | $579.72M |
Build a custom stock screener for Cardiovascular Systems, Inc. (CSII) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cardiovascular Systems, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Cardiovascular Systems, Inc. (CSII) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Cardiovascular Systems, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Cardiovascular Systems, Inc.'s ROE?
How is the ROE calculated for Cardiovascular Systems, Inc. (CSII)?
What is the highest ROE for Cardiovascular Systems, Inc. (CSII)?
What is the 3-year average ROE for Cardiovascular Systems, Inc. (CSII)?
What is the 5-year average ROE for Cardiovascular Systems, Inc. (CSII)?
How does the current ROE for Cardiovascular Systems, Inc. (CSII) compare to its historical average?